<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Zhongchao Inc. — News on 6ix</title>
<link>https://6ix.com/company/zhongchao-inc</link>
<description>Latest news and press releases for Zhongchao Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 29 May 2026 14:02:10 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/zhongchao-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835dd5978dffbe2df124ae2.webp</url>
<title>Zhongchao Inc.</title>
<link>https://6ix.com/company/zhongchao-inc</link>
</image>
<item>
<title>Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-pricing-of-dollar5-million-best-efforts-public-offering</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-pricing-of-dollar5-million-best-efforts-public-offering</guid>
<pubDate>Fri, 29 May 2026 14:02:10 GMT</pubDate>
<description>Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public</description>
</item>
<item>
<title>Zhongchao Inc. Announces 1-for-8 Share Consolidation</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-1-for-8-share-consolidation</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-1-for-8-share-consolidation</guid>
<pubDate>Thu, 26 Feb 2026 13:30:00 GMT</pubDate>
<description>Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-8 share consolidation of the Company's ordinary shares of US$0.001 par value each (the "Share Consolidation").</description>
</item>
<item>
<title>Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-successful-medication-assistance-services-for-over-7000-sle-patients-with-approximately-130000-units-of-medications</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-successful-medication-assistance-services-for-over-7000-sle-patients-with-approximately-130000-units-of-medications</guid>
<pubDate>Tue, 12 Mar 2024 04:00:00 GMT</pubDate>
<description>SHANGHAI, March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Announces 1-for-10 Share Consolidation</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-1-for-10-share-consolidation</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-1-for-10-share-consolidation</guid>
<pubDate>Tue, 27 Feb 2024 05:00:00 GMT</pubDate>
<description>SHANGHAI, Feb. 27, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-collaborates-with-a-public-health-foundation-to-support-sustainable-and-effective-cancer-treatments</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-collaborates-with-a-public-health-foundation-to-support-sustainable-and-effective-cancer-treatments</guid>
<pubDate>Mon, 11 Dec 2023 05:00:00 GMT</pubDate>
<description>SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-launches-breast-cancer-follow-up-visit-and-health-management-patient-guide-program-on-breast-cancer-awareness-day</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-launches-breast-cancer-follow-up-visit-and-health-management-patient-guide-program-on-breast-cancer-awareness-day</guid>
<pubDate>Mon, 23 Oct 2023 04:00:00 GMT</pubDate>
<description>SHANGHAI, Oct. 23, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-introduces-pro-based-disease-management-model-for-lung-cancer-patients</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-introduces-pro-based-disease-management-model-for-lung-cancer-patients</guid>
<pubDate>Mon, 25 Sep 2023 04:00:00 GMT</pubDate>
<description>SHANGHAI, Sept. 25, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-serving-over-10000-breast-cancer-patients-with-its-comprehensive-disease-management</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-serving-over-10000-breast-cancer-patients-with-its-comprehensive-disease-management</guid>
<pubDate>Thu, 24 Aug 2023 04:00:00 GMT</pubDate>
<description>SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-partners-with-ximalaya-to-launch-the-first-audio-course-series-for-cancer-education</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-partners-with-ximalaya-to-launch-the-first-audio-course-series-for-cancer-education</guid>
<pubDate>Tue, 11 Jul 2023 04:00:00 GMT</pubDate>
<description>SHANGHAI, July 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-launch-digital-online-education-platform-for-common-diseases-clinical-diagnosis-and-treatment</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-launch-digital-online-education-platform-for-common-diseases-clinical-diagnosis-and-treatment</guid>
<pubDate>Mon, 12 Jun 2023 04:00:00 GMT</pubDate>
<description>SHANGHAI, June 12, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Announces Strategic Cooperation with Ximalaya</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-strategic-cooperation-with-ximalaya</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-strategic-cooperation-with-ximalaya</guid>
<pubDate>Fri, 12 May 2023 04:00:00 GMT</pubDate>
<description>SHANGHAI, May 12, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in China</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-naiditaweir-enrolled-as-a-listed-online-procurement-drug-in-ten-provincesdistricts-cities-in-china</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-naiditaweir-enrolled-as-a-listed-online-procurement-drug-in-ten-provincesdistricts-cities-in-china</guid>
<pubDate>Mon, 08 May 2023 04:00:00 GMT</pubDate>
<description>SHANGHAI, May 8, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' Health</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-partners-with-a-public-health-foundation-to-safeguard-cancer-patients-health</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-partners-with-a-public-health-foundation-to-safeguard-cancer-patients-health</guid>
<pubDate>Mon, 24 Apr 2023 04:00:00 GMT</pubDate>
<description>SHANGHAI, April 24, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-launch-of-health-education-intelligent-content-production-platform</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-launch-of-health-education-intelligent-content-production-platform</guid>
<pubDate>Thu, 30 Mar 2023 04:00:00 GMT</pubDate>
<description>SHANGHAI, March 30, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full Satisfaction</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-releases-survey-results-for-bone-marrow-cancer-patient-services-with-more-than-80percent-patients-indicating-full-satisfaction</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-releases-survey-results-for-bone-marrow-cancer-patient-services-with-more-than-80percent-patients-indicating-full-satisfaction</guid>
<pubDate>Mon, 13 Mar 2023 04:00:00 GMT</pubDate>
<description>SHANGHAI, March 13, 2023 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-renews-partnership-with-johnson-and-johnson-china</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-renews-partnership-with-johnson-and-johnson-china</guid>
<pubDate>Thu, 23 Feb 2023 05:00:00 GMT</pubDate>
<description>SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Announces the Application of ChatGPT for Its MDMOOC Platform to Assist Physicians in Clinic Decision Making and Improve Treatment Efficiency</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-the-application-of-chatgpt-for-its-mdmooc-platform-to-assist-physicians-in-clinic-decision-making-and-improve-treatment-efficiency</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-the-application-of-chatgpt-for-its-mdmooc-platform-to-assist-physicians-in-clinic-decision-making-and-improve-treatment-efficiency</guid>
<pubDate>Mon, 13 Feb 2023 05:00:00 GMT</pubDate>
<description>SHANGHAI, Feb. 13, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and Experience</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-the-application-of-chatgpt-to-elevate-patient-management-service-capabilities-and-experience</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-the-application-of-chatgpt-to-elevate-patient-management-service-capabilities-and-experience</guid>
<pubDate>Wed, 08 Feb 2023 05:00:00 GMT</pubDate>
<description>SHANGHAI, Feb. 8, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-introduction-of-indian-anti-influenza-drugs-to-china</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-announces-introduction-of-indian-anti-influenza-drugs-to-china</guid>
<pubDate>Tue, 31 Jan 2023 05:00:00 GMT</pubDate>
<description>SHANGHAI, Jan. 31, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
<item>
<title>Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment</title>
<link>https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-launches-medication-management-assistance-mini-program-to-facilitate-cancer-treatment</link>
<guid isPermaLink="true">https://6ix.com/company/zhongchao-inc/news/zhongchao-inc-launches-medication-management-assistance-mini-program-to-facilitate-cancer-treatment</guid>
<pubDate>Thu, 19 Jan 2023 05:00:00 GMT</pubDate>
<description>SHANGHAI, Jan. 19, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering</description>
</item>
</channel>
</rss>